Cargando…
P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428865/ http://dx.doi.org/10.1097/01.HS9.0000969164.32364.1c |
| _version_ | 1785090572557484032 |
|---|---|
| author | Hermans, Sjoerd van Norden, Yvette van Werkhoven, Erik Dinmohamed, Avinash Huijgens, Peter Ossenkoppele, Gert Huls, Gerwin Löwenberg, Bob Pabst, Thomas Breems, Dimitri Postmus, Douwe Pignatti, Francesco Versluis, Jurjen Cornelissen, Jan |
| author_facet | Hermans, Sjoerd van Norden, Yvette van Werkhoven, Erik Dinmohamed, Avinash Huijgens, Peter Ossenkoppele, Gert Huls, Gerwin Löwenberg, Bob Pabst, Thomas Breems, Dimitri Postmus, Douwe Pignatti, Francesco Versluis, Jurjen Cornelissen, Jan |
| author_sort | Hermans, Sjoerd |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428865 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288652023-08-17 P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS Hermans, Sjoerd van Norden, Yvette van Werkhoven, Erik Dinmohamed, Avinash Huijgens, Peter Ossenkoppele, Gert Huls, Gerwin Löwenberg, Bob Pabst, Thomas Breems, Dimitri Postmus, Douwe Pignatti, Francesco Versluis, Jurjen Cornelissen, Jan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428865/ http://dx.doi.org/10.1097/01.HS9.0000969164.32364.1c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Hermans, Sjoerd van Norden, Yvette van Werkhoven, Erik Dinmohamed, Avinash Huijgens, Peter Ossenkoppele, Gert Huls, Gerwin Löwenberg, Bob Pabst, Thomas Breems, Dimitri Postmus, Douwe Pignatti, Francesco Versluis, Jurjen Cornelissen, Jan P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
| title | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
| title_full | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
| title_fullStr | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
| title_full_unstemmed | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
| title_short | P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS |
| title_sort | p565: real-world data as supplementary controls for the prospective randomized hovon-103 trial in intensively treated elderly acute myeloid leukemia patients |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428865/ http://dx.doi.org/10.1097/01.HS9.0000969164.32364.1c |
| work_keys_str_mv | AT hermanssjoerd p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT vannordenyvette p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT vanwerkhovenerik p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT dinmohamedavinash p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT huijgenspeter p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT ossenkoppelegert p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT hulsgerwin p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT lowenbergbob p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT pabstthomas p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT breemsdimitri p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT postmusdouwe p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT pignattifrancesco p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT versluisjurjen p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients AT cornelissenjan p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients |